ACT-AD

Founded in 2005, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition is a group of more than 50 national nonprofit organizations, chaired by the Alliance for Aging Research, urgently working to speed up the development of potential cures and more effective treatments for Alzheimer’s disease (AD). Learn more at ACT-AD.org

Public Comments

Alliance Comments on PDUFA VI Commitment Letter

August 23, 2016

Public Comments

FY17 ACT-AD FDA Appropriations Request Letter

March 17, 2016

Public Comments

Alzheimer’s Disease PCORI Priorities Letter

January 5, 2016

Public Comments

ACT-AD Letter to DeGette and Upton Re: 21st Century Cures

May 15, 2015

Public Comments

FY 2016 L-HHS Alzheimer’s Disease Letter

March 11, 2015

Public Comments

ACT-AD 21st Century Cures Letter

February 10, 2015

+ All documents related to "ACT-AD"

A Quick Look at Alzheimer’s (Film 1): What is Alzheimer’s Disease?

A Quick Look at Alzheimer’s (Film 2): An Urgent Epidemic

A Quick Look at Alzheimer’s (Film 3): The Race to the Cure

A Quick Look at Alzheimer’s (Film 4): A Message for Patients and Their Families

Alzheimer’s Disease (ACT-AD) Coalition Goes to Barcelona

October 31, 2018

ACT-AD Coalition Letter on FDA Early Alzheimer’s Disease Guidance

June 15, 2018

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

December 1, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

November 7, 2017

Alzheimer’s Association International Conference Recap

August 10, 2017

Webinar on Research Framework for Alzheimer’s Disease/July 25

July 20, 2017

Alzheimer’s Disease Begins Before Symptoms Start, Researchers Say

June 19, 2017

ACT-AD Coalition’s Webinar on Symptomatic Relief for Alzheimer’s Available Now

March 24, 2017

+ All Blog posts related to "ACT-AD"

Alliance-Led Sign-On Letter Opposes Per Capita Caps, Stresses Their Impact on Individuals with Alzheimer’s Disease and Related Dementias

June 22, 2017

Experts Explore Federal Agency Collaborations to Close Alzheimer’s Disease Research Gaps at ACT-AD Coalition Annual Meeting

November 16, 2016

Leading Experts Assess the Current State of Alzheimer’s Disease Therapeutic Development

September 16, 2015

Leading Experts Discuss Clinical Meaningfulness in Drug Development for Early Alzheimer’s Disease

November 6, 2014

Tweets Do Tell: Alzhemier’s Not a High Priority for Research Funding

May 13, 2013

Statement on FDA Draft Guidance for Alzheimer’s Drug Development

February 7, 2013

Ready for Prime Time

February 1, 2012

Use Biomarkers in Alzheimer’s Disease Clinical Trials

January 4, 2012

+ All Press releases related to "ACT-AD"